✦ LIBER ✦

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

✍ Scribed by Christoph Seidel; Jonas Busch; Steffen Weikert; Sandra Steffens; Martin Fenner; Arnold Ganser; Viktor Grünwald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of percentage of tumour burd

✍ Juan Barbastefano; Jorge A. Garcia; Paul Elson; Laura S. Wood; Brian R. Lane; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Cessation of vascular endothelial growth

✍ Sarmad Sadeghi; Laurence Albiges; Laura S. Wood; Shari L. Black; Timothy D. Gill 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Carbonic anhydrase IX and pathological f

✍ Toni K. Choueiri; Meredith M. Regan; Jonathan E. Rosenberg; William K. Oh; Jessi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Two phase 2 trials of the novel Akt inhi

✍ Daniel C. Cho; Thomas E. Hutson; Wolfram Samlowski; Peter Sportelli; Brad Somer; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Re: Two Phase 2 Trials of the Novel Akt

✍ Taneja, Samir S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 104 KB

Comparative efficacy of vascular endothe

✍ Kwonoh Park, Jae-Lyun Lee, Inkeun Park, Seongjoon Park, Yongcheol Ahn, Jin-Hee A 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 193 KB